References
- St-Vil D, Shaw KS, Lallier M, et al. Chromosomal anomalies in newborns with omphalocele. J Pediatr Surg. 1996;31(6):831–834.
- Nyberg DA, Fitzsimmons J, Mack LA, et al. Chromosomal abnormalities in fetuses with omphalocele. Significance of omphalocele contents. J Ultrasound Med. 1989;8(6):299–308.
- Snijders RJ, Brizot ML, Faria M, et al. Fetal exomphalos at 11 to 14 weeks of gestation. J Ultrasound Med. 1995;14(8):569–574.
- Akolekar R, Betta J, Picciarelli G, et al. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2015;45(1):16–26.
- Iwarsson E, Jacobsson B, Dagerhamn J, et al. Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population - a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2017;96(1):7–18.
- Nshimyumukiza L, Menon S, Hina H, et al. Cell-free DNA noninvasive prenatal screening for aneuploidy versus conventional screening: a systematic review of economic evaluations. Clin Genet. 2018;94(1):3–21.
- De Veciana M, Major CA, Porto M. Prediction of an abnormal karyotype in fetuses with omphalocele. Prenat Diagn. 1994;14(6):487–492.
- Tassin M, Descriaud C, Elie C, et al. Omphalocele in the first trimester: prediction of perinatal outcome. Prenat Diagn. 2013;33(5):497–501.
- Gil MM, Accurti V, Santacruz B, et al. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. 2017;50(3):302–314.
- Van Opstal D, de Vries F, Govaerts L, et al. Benefits and burdens of using a SNP array in pregnancies at increased risk for the common aneuploidies. Hum Mutat. 2015;36(3):319–326.
- D’Amours G, Kibar Z, Mathonnet G, et al. Whole-genome array CGH identifies pathogenic copy number variations in fetuses with major malformations and a normal karyotype. Clin Genet. 2012;81(2):128–141.
- Chen CP. Chromosomal abnormalities associated with omphalocele. Taiwan J Obstet Gynecol. 2007;46(1):1–8.
- Wapner RJ, Martin CL, Levy B, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med. 2012;367(23):2175–2184.
- Shaffer LG, Rosenfeld JA, Dabell MP, et al. Detection rates of clinically significant genomic alterations by microarray analysis for specific anomalies detected by ultrasound. Prenat Diagn. 2012;32(10):986–995.
- Hillman SC, McMullan DJ, Hall G, et al. Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2013;41(6):610–620.
- Hartwig TS, Ambye L, Sørensen S, et al. Discordant non-invasive prenatal testing (NIPT) – a systematic review. Prenat Diagn. 2017;37(6):527–539.
- Van Opstal D, Srebniak MI, Polak J, et al. False negative NIPT results: risk figures for chromosomes 13, 18 and 21 based on chorionic villi results in 5967 cases and literature review. PLoS One. 2016;11(1):e0146794.
- Yaron Y. The implications of non-invasive prenatal testing failures: a review of an under-discussed phenomenon. Prenat Diagn. 2016;36(5):391–396.
- Chan N, Smet ME, Sandow R, et al. Implications of failure to achieve a result from prenatal maternal serum cell-free DNA testing: a historical cohort study. BJOG. 2018;125(7):848–855.
- Lefkowitz RB, Tynan JA, Liu T, et al. Clinical validation of a noninvasive prenatal test for genome wide detection of fetal copy number variants. Am J Obstet Gynecol. 2016;215(2):227.e1–227.e16.
- Yu SC, Jiang P, Choy KW, et al. Noninvasive prenatal molecular karyotyping from maternal plasma. PLoS One. 2013;8(4):e60968.